Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash & Equivalents: 2022-2025

Historic Cash & Equivalents for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $498.4 million.

  • Immunocore Holdings' Cash & Equivalents fell 7.32% to $498.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $498.4 million, marking a year-over-year decrease of 7.32%. This contributed to the annual value of $455.7 million for FY2024, which is 2.96% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Cash & Equivalents is $498.4 million, which was up 2.15% from $487.9 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Cash & Equivalents peaked at $832.8 million during Q1 2024, and registered a low of $402.5 million during Q4 2022.
  • Over the past 3 years, Immunocore Holdings' median Cash & Equivalents value was $493.2 million (recorded in 2025), while the average stood at $529.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first increased by 9.98% in 2023, then crashed by 42.74% in 2025.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Cash & Equivalents stood at $402.5 million in 2022, then increased by 9.98% to $442.6 million in 2023, then climbed by 2.96% to $455.7 million in 2024, then declined by 7.32% to $498.4 million in 2025.
  • Its last three reported values are $498.4 million in Q3 2025, $487.9 million for Q2 2025, and $476.8 million during Q1 2025.